MS functional composite: Relation to disease phenotype and disability strata

Neurology

Volumn 54, Issue 6, 2000, Pages 1233-1239

  Kalkers, N F ^a   De Groot, V ^b   Lazeron, R H C ^b   Killestein, J ^b   Ader H J ^b   Barkhof, F ^b   Lankhorst, G J ^b   Polman, C H ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

Expanded Disability Status Scale; MS; MS Functional Composite

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; CORRELATION FUNCTION; DISABILITY; DISEASE COURSE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; OUTCOMES RESEARCH; PHENOTYPE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION PROCESS;

EID: 0034724163     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.54.6.1233     Document Type: Article

References (16)

1. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33:1444-1452.
2. Whitaker JN, McFarland HF, Rudge P, Reingold SC. Outcomes assessment in multiple sclerosis clinical trials: a critical analysis. Mult Scler 1995;1:37-47.
3. Rudick RA, Antel J, Confavreux C, et al. Clinical outcomes assessment in multiple sclerosis. Ann Neurol 1996;40:469-479
4. Rudick RA, Antel J, Confavreux C, et al. Recommendations from the National Multiple Sclerosis Society Clinical Outcomes Assessment Task Force. Ann Neurol 1997;42:379-382.
5. Cutter GC, Baier ML, Rudick RA, et al. Development of a Multiple Sclerosis Functional Composite as a clinical trial outcome measure. Brain 1999;122:871-882.
6. Poser CM, Paty D, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983;13:2227-2231.
7. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996;46:907-911.
8. Bohannon RW. Comfortable and maximum walking speed of adults aged 20-79 years: reference values and determinants. Age Ageing 1997;26:15-19.
9. Mathiowetz V, Weber G, Kashman N, Volland G. Adult norms for 9-hole peg test of finger dexterity. Occup Ther J Res 1985a; 5:24-38.
10. Goodkin DE, Hertsgaard D, Seminary J. Upper extremity function in multiple sclerosis: improving assessment sensitivity with box-and-block and nine-hole peg tests. Arch Phys Med Rehab 1988;69:850-854.
11. Gronwall DMA. Paced auditory serial addition task: a measure of recovery from concussion. Percept Mot Skills 1977;44: 367-373.
12. Wiens AN, Fuller KH, Crossen JR. Paced auditory serial addition test: adult norms and moderator variables. J Clin Exp Neuropsychol 1997;19:473-483.
13. Thompson AJ, Polman CH, Miller DH, et al. Primary progressive multiple sclerosis. Brain 1997;120:1085-1096.
14. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter GC. Administration and scoring manual for the Multiple Sclerosis Functional Composite measure (MSFC). New York: Demos, 1999.
15. Fischer JS, Cohen JA, Cutter GC, et al. Intra- and inter-rater reliability of the Multiple Sclerosis Functional Composite. Neurology 1999;52:548. Abstract.
16. Cohen JA, Cutter GC, Simonian NA, et al. Utilization of the Multiple Sclerosis Functional Composite as an outcome measure in the phase 3 trial of interferon beta-1a (Avonex) in secondary progressive multiple sclerosis (IMPACT). Neurology 1999;52:548. Abstract.